Cargando…
Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974319/ https://www.ncbi.nlm.nih.gov/pubmed/33747972 http://dx.doi.org/10.3389/fonc.2021.661128 |
| _version_ | 1783666916216274944 |
|---|---|
| author | Chen, Qitong Ouyang, Dengjie Anwar, Munawar Xie, Ning Wang, Shouman Fan, Peizhi Qian, Liyuan Chen, Gannong Zhou, Enxiang Guo, Lei Gu, Xiaowen Ding, Boni Yang, Xiaohong Liu, Liping Deng, Chao Xiao, Zhi Li, Jing Wang, Yunqi Zeng, Shan Hu, Jinhui Zhou, Wei Qiu, Bo Wang, Zhongming Weng, Jie Liu, Mingwen Li, Yi Tang, Tiegang Wang, Jianguo Zhang, Hui Dai, Bin Tang, Wuping Wu, Tao Xiao, Maoliang Li, Xiantao Liu, Hailong Li, Lai Yi, Wenjun Ouyang, Quchang |
| author_facet | Chen, Qitong Ouyang, Dengjie Anwar, Munawar Xie, Ning Wang, Shouman Fan, Peizhi Qian, Liyuan Chen, Gannong Zhou, Enxiang Guo, Lei Gu, Xiaowen Ding, Boni Yang, Xiaohong Liu, Liping Deng, Chao Xiao, Zhi Li, Jing Wang, Yunqi Zeng, Shan Hu, Jinhui Zhou, Wei Qiu, Bo Wang, Zhongming Weng, Jie Liu, Mingwen Li, Yi Tang, Tiegang Wang, Jianguo Zhang, Hui Dai, Bin Tang, Wuping Wu, Tao Xiao, Maoliang Li, Xiantao Liu, Hailong Li, Lai Yi, Wenjun Ouyang, Quchang |
| author_sort | Chen, Qitong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7974319 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79743192021-03-20 Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis Chen, Qitong Ouyang, Dengjie Anwar, Munawar Xie, Ning Wang, Shouman Fan, Peizhi Qian, Liyuan Chen, Gannong Zhou, Enxiang Guo, Lei Gu, Xiaowen Ding, Boni Yang, Xiaohong Liu, Liping Deng, Chao Xiao, Zhi Li, Jing Wang, Yunqi Zeng, Shan Hu, Jinhui Zhou, Wei Qiu, Bo Wang, Zhongming Weng, Jie Liu, Mingwen Li, Yi Tang, Tiegang Wang, Jianguo Zhang, Hui Dai, Bin Tang, Wuping Wu, Tao Xiao, Maoliang Li, Xiantao Liu, Hailong Li, Lai Yi, Wenjun Ouyang, Quchang Front Oncol Oncology Frontiers Media S.A. 2021-03-05 /pmc/articles/PMC7974319/ /pubmed/33747972 http://dx.doi.org/10.3389/fonc.2021.661128 Text en Copyright © 2021 Chen, Ouyang, Anwar, Xie, Wang, Fan, Qian, Chen, Zhou, Guo, Gu, Ding, Yang, Liu, Deng, Xiao, Li, Wang, Zeng, Hu, Zhou, Qiu, Wang, Weng, Liu, Li, Tang, Wang, Zhang, Dai, Tang, Wu, Xiao, Li, Liu, Li, Yi and Ouyang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Chen, Qitong Ouyang, Dengjie Anwar, Munawar Xie, Ning Wang, Shouman Fan, Peizhi Qian, Liyuan Chen, Gannong Zhou, Enxiang Guo, Lei Gu, Xiaowen Ding, Boni Yang, Xiaohong Liu, Liping Deng, Chao Xiao, Zhi Li, Jing Wang, Yunqi Zeng, Shan Hu, Jinhui Zhou, Wei Qiu, Bo Wang, Zhongming Weng, Jie Liu, Mingwen Li, Yi Tang, Tiegang Wang, Jianguo Zhang, Hui Dai, Bin Tang, Wuping Wu, Tao Xiao, Maoliang Li, Xiantao Liu, Hailong Li, Lai Yi, Wenjun Ouyang, Quchang Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis |
| title | Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis |
| title_full | Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis |
| title_fullStr | Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis |
| title_full_unstemmed | Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis |
| title_short | Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis |
| title_sort | corrigendum: effectiveness and safety of pyrotinib, and association of biomarker with progression-free survival in patients with her2-positive metastatic breast cancer: a real-world, multicentre analysis |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974319/ https://www.ncbi.nlm.nih.gov/pubmed/33747972 http://dx.doi.org/10.3389/fonc.2021.661128 |
| work_keys_str_mv | AT chenqitong corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT ouyangdengjie corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT anwarmunawar corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT xiening corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT wangshouman corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT fanpeizhi corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT qianliyuan corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT chengannong corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT zhouenxiang corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT guolei corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT guxiaowen corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT dingboni corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT yangxiaohong corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT liuliping corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT dengchao corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT xiaozhi corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT lijing corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT wangyunqi corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT zengshan corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT hujinhui corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT zhouwei corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT qiubo corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT wangzhongming corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT wengjie corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT liumingwen corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT liyi corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT tangtiegang corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT wangjianguo corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT zhanghui corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT daibin corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT tangwuping corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT wutao corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT xiaomaoliang corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT lixiantao corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT liuhailong corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT lilai corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT yiwenjun corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis AT ouyangquchang corrigendumeffectivenessandsafetyofpyrotinibandassociationofbiomarkerwithprogressionfreesurvivalinpatientswithher2positivemetastaticbreastcancerarealworldmulticentreanalysis |